Enantioselective inhibition of the epidermal growth factor receptor tyrosine kinase by 4-(α-phenethylamino)quinazolines
- 31 December 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 3 (12) , 1651-1656
- https://doi.org/10.1016/0968-0896(95)00149-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Tyrosine kinase inhibitors. 7. 7-amino-4-(phenylamino)- and 7-amino-4-[(phenylmethyl)amino]pyrido[4,3-d]pyrimidines: a new class of inhibitors of the tyrosine kinase activity of the epidermal growth factor receptorJournal of Medicinal Chemistry, 1995
- Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor.Journal of Medicinal Chemistry, 1995
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994
- Epidermal growth factor receptor tyrosine kinaseBiochemical Pharmacology, 1994
- Neu and its ligands: From an oncogene to neural factorsBioEssays, 1993
- EGF receptor in neoplasia and metastasisCancer and Metastasis Reviews, 1993
- The role of erbB2 signal transduction pathways in human breast cancerBreast Cancer Research and Treatment, 1993
- The type 1 (EGFR-related) family of growth factor receptors and their ligandsProgress in Growth Factor Research, 1992
- Chapter 18. Protein Tyrosine Kinases and CancerPublished by Elsevier ,1992
- RESEARCHES ON QUINAZOLINES (TWENTY-FIRST PAPER). ON CERTAIN QUINAZOLINE OXYGEN ETHERS OF THE TYPE —N:C(OR)— AND THE ISOMERIC —NR.CO— COMPOUNDS.Journal of the American Chemical Society, 1909